Job Summary
5 - 10 Years
Registration, Quality Control, Q.A.
Regulatory Affairs
Biotechnology/Pharmaceutical/Medicine
Post Graduation - M.Pharm, M.Sc School & Graduation - B.Pharm
Ultratech India Limited is an ISO certified Pharmaceuticals and Bulk drugs manufacturing firm based
in Navi Mumbai.
Our manufacturing plant is located in Taloja MIDC and Corporate Office is at Vashi, New Mumbai.
Designation: Regulatory Affairs Executive/Officer.
Experience: Minimum 4 years in Quality Assurance Documentation for preparation of Drug Dossiers of a Formulations manufacturing unit.
Qualification : B.Pharm, B.Sc.
Candidate's Desired profile:
Past exposure in preparation of Drug Dossiers for regulated markets.
Previous Documentation exposure in various sections like tablets / capsules / Liquid orals /
injectables preferred.
Knowledge of interpreting Q.C. reports.
Location: Vashi
Interested candidates please send your updated resume with the following details:
Current Salary, Expected Salary and Notice Period
e-mail ID: hrd@ultratechindia.com
in Navi Mumbai.
Our manufacturing plant is located in Taloja MIDC and Corporate Office is at Vashi, New Mumbai.
Designation: Regulatory Affairs Executive/Officer.
Experience: Minimum 4 years in Quality Assurance Documentation for preparation of Drug Dossiers of a Formulations manufacturing unit.
Qualification : B.Pharm, B.Sc.
Candidate's Desired profile:
Past exposure in preparation of Drug Dossiers for regulated markets.
Previous Documentation exposure in various sections like tablets / capsules / Liquid orals /
injectables preferred.
Knowledge of interpreting Q.C. reports.
Location: Vashi
Interested candidates please send your updated resume with the following details:
Current Salary, Expected Salary and Notice Period
e-mail ID: hrd@ultratechindia.com
Company Details [Ultratech India Limited]
Ultratech India Limited is an ISO certified Pharmaceuticals and Bulk drugs manufacturing firm based in Navi Mumbai. Our manufacturing plant is located in Taloja MIDC and office is at Vashi, New Mumbai.
0 comments:
Post a Comment